# Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides

@article{Hartmann1997DistinctSO,
title={Distinct sites of intracellular production for Alzheimer's disease A$\beta$40/42 amyloid peptides},
author={Tobias Hartmann and Sophie Bieger and Babara Br{\"u}hl and Pentti J. Tienari and Nobuo Ida and David Allsop and Gareth W. Roberts and Colin L. Masters and Carlos G Dotti and Klaus Unsicker and Konrad T. Beyreuther},
journal={Nature Medicine},
year={1997},
volume={3},
pages={1016-1020}
}
• Published 1 September 1997
• Biology, Chemistry
• Nature Medicine
The Alzheimer amyloid precursor protein (APP) is cleaved by several proteases, the most studied, but still unidentified ones, are those involved in the release of a fragment of APP, the amyloidogenic β-protein Aβ. Proteolysis by γ-secretase is the last processing step resulting in release of Aβ. Cleavage occurs after residue 40 of Aβ [Aβ(1–40)], occasionally after residue 42 [Aβ(1–42)]. Even slightly increased amounts of this Aβ(1–42) might be sufficient to cause Alzheimer's disease (AD…
723 Citations
The involvement of lipid rafts in Alzheimer's disease (Review)
• Biology
Molecular membrane biology
• 2006
Evidence suggests that amyloidogenic APP processing may preferentially occur in the cholesterol-rich regions of membranes known as lipid rafts, and that changes in cholesterol levels could exert their effects by altering the distribution of APP-cleaving enzymes within the membrane.
Proteolytic processing of Alzheimer's disease associated proteins.
• Biology, Chemistry
Journal of neural transmission. Supplementum
• 1998
It is demonstrated that PS proteins are involved in NOTCH signaling FAD causing mutations interfere with the biological function of PS proteins in NotCH signaling.
Closing in on the amyloid cascade
• Biology
Molecular Neurobiology
• 2007
What is know about BACE and the presenilins, focusing on their capacity as secretases, as well as the options for therapeutic advancement the careful characterization of these proteins will provide are discussed.
Review Alzheimer ß-amyloid peptides: normal and abnormal localization
• Biology
• 2002
Current knowledge of the localization of both intracellular and extracellular As is outlined, which shows that As is generated in the ER, Golgi, and endosomal/lysosomal system and causes toxicity to surrounding neurons as extacellular SP.
APP processing in Alzheimer's disease
• Biology, Chemistry
Molecular Brain
• 2010
Current knowledge of APP processing regulation as well as the patho/physiological functions of APP and its metabolites are reviewed.
Post-translational processing of proteins implicated in the pathogenesis of Alzheimer's disease
This work emphasised the need to use antibodies that distinguish between APP and APLP2 (which does not contain the beta-amyloid sequence) in studies of APP processing and amyloidogenesis, since only APP was concentrated in compartments beyond the Golgi apparatus.
The amyloid precursor protein of Alzheimer’s disease and the Aβ peptide
• Biology, Chemistry
• 1999
The central role of amyloid in the pathogenesis of Alzheimer’s disease is focused on, and the site of γ‐secretase cleavage is critical to the development of ameloid deposits.
Cellular mechanisms of beta-amyloid production and secretion.
• Biology
Proceedings of the National Academy of Sciences of the United States of America
• 1999
Peptide aldehyde inhibitors that block Abeta production by inhibiting gamma-secretase cleavage of beta-CTF have been discovered, indicating that PS-1 expression is important for gamma- secretase cleavages.
INTRACELLULAR DYNAMICS OF ALZHEIMER DISEASE-RELATED PROTEINS
The major premise of this thesis was to follow the turnover of proteins in the cell: from synthesis and quality control in the endoplasmic reticulum, trafficking along the secretory pathway to a protein’s site of action and finally protein degradation by the proteasome, and demonstrated that all these pathways are significant for neurodegenerative disorders, such as Alzheimer's disease.

## References

SHOWING 1-10 OF 37 REFERENCES
Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42*
• Biology
The Journal of Biological Chemistry
• 1997
It is demonstrated that the γ-secretase cleavage of Aβ after amino acid 42 can occur within the ER and later within the secretory pathway within the Golgi.
Normal Cellular Processing of the β‐Amyloid Precursor Protein Results in the Secretion of the Amyloid β Peptide and Related Molecules a
• Biology
• 1993
The finding that Aβ is produced continuously by normal processing in tissue culture cells is described and it is concluded that lysosomes may not play a predominant role in the formation of 3 and 4 kDa peptides.
Amyloid β-peptide is produced by cultured cells during normal metabolism
• Biology
Nature
• 1992
The unexpected identification of the 4K (Mr 4,000) Aβ and a truncated form of Aβ in media from cultures of primary cells and untransfected and β-APP-transfected cell lines grown under normal conditions provide the basis for using simple cell culture systems to identify drugs that block the formation or release of A β, the primary protein constituent of the senile plaques of Alzheimer's disease.
Intracellular and secreted Alzheimer beta-amyloid species are generated by distinct mechanisms in cultured hippocampal neurons.
• Biology
Proceedings of the National Academy of Sciences of the United States of America
• 1997
It is shown that hippocampal neurons are able to utilize an alternate pathway to produce intracellular beta A4, and a common feature of two types of APP mutations implicated in early-onset AD is their increased production of C-terminally elongatedbeta A4 (beta 42), both intra- and extracellularly.
Intracellular production of beta A4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of coupling to the secretion of the amyloid precursor protein.
• Biology
Biochemistry
• 1995
The results therefore demonstrate a double dissociation between the secretion of sAPP and beta A4 in the SH-SY5Y cell line, and supports previous studies which show that metalloproteases are involved in the biogenesis of Beta A4.
Production of the Alzheimer amyloid beta protein by normal proteolytic processing.
• Biology
Science
• 1992
Human mononuclear leukemic cells expressing a beta AP-bearing, carboxyl-terminal beta APP derivative released significant amounts of a soluble 4-kilodalton beta AP derivative essentially identical to the beta AP deposited in Alzheimer's disease.